Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of AS03B-adjuvanted H5N1 candidate vaccines in children
2011-004751-39Phase 3
- Sponsor
- GSK
- Start
- Apr 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of H5N1 A/turkey/Turkey/1/2005 with AS03B, H5N1 A/Indonesia/05/2005 + AS03B in Influenza A H5N1 infection (H5N1), hepatitis A (HAV), sponsored by GSK.
02
Drugs
H5N1 A/turkey/Turkey/1/2005 with AS03BH5N1 A/Indonesia/05/2005 + AS03B
03
Conditions
Influenza A H5N1 infection (H5N1)hepatitis A (HAV)
Beyond the preview
Go deeper on 2011-004751-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004751-39.